Phytomedics

About Phytomedics

Phytomedics Inc., founded in 1996 by Ilya Raskin, operated within the biopharmaceutical sector with a focus on plant-based therapeutics. The firm was established to discover, develop, and manufacture novel pharmaceuticals derived from plants, leveraging proprietary platform technologies.

The company's strategic direction involved merging healthcare with plant biotechnology. Its core business was centered on creating a diverse portfolio of botanical products. This included botanical drugs, as defined by the U.S. FDA, alongside nutraceuticals, dietary supplements, and cosmeceuticals. The operational model appears to have been based on research and development to create proprietary assets, a common approach for biotech firms which can lead to licensing agreements or further in-house development. Phytomedics secured $16.5 million in total funding across two major rounds. A Series A round in January 2004 raised $7.5 million, followed by a Series B round in June 2007 that brought in an additional $9 million. The primary investors participating in these rounds were Burrill and Company and Inventages. According to industry data, the company is no longer active.